Expression pattern of the thioredoxin system in human endothelial progenitor cells and endothelial cells under hypoxic injury

Korean Circulation Journal

Volumn 40, Issue 12, 2010, Pages 651-658

  Park, Keon Jae ^a   Kim, Yeon Jeong ^a   Choi, Eun Ju ^a   Park, No Kwan ^a   Kim, Gi Hyun ^a   Kim, Sang Min ^a   Lee, Sang Yeub ^a   Bae, Jang Whan ^a   Hwang, Kyung Kuk ^a   Kim, Dong Woon ^a   Cho, Myeong Chan ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Apoptosis; Cell hypoxia; Endothelial cells; Thioredoxins

Indexed keywords

BCL2 RELATED PROTEIN A1; LIPOCORTIN 5; OXYGEN; PHYCOERYTHRIN; PROTEIN BAX; THIOREDOXIN; THIOREDOXIN REDUCTASE;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL SURVIVAL; CELL TYPE; DISEASE MARKER; ENDOTHELIUM CELL; FLOW CYTOMETRY; HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HYPOXIA; ISCHEMIC HEART DISEASE; LAKE; MEDICAL APPARATUS, EQUIPMENT AND SUPPLIES; MOLECULE; OXIDATIVE STRESS; STEM CELL; UMBILICAL VEIN ENDOTHELIAL CELL; UNITED STATES; VASCULAR TISSUE;

EID: 79551695450     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2010.40.12.651     Document Type: Article

References (30)

1. Melley DD, Evans TW, Quinlan GJ. Redox regulation of neutrophil apoptosis and the systemic inflammatory response syndrome. Clin Sci 2005;108:413-24. (Pubitemid 40685671)
2. Krohn K, Maier J, Paschke R. Mechanism of disease: hydrogen peroxide. DNA damage and mutagenesis in the development of thyroid tumors. Nat Clin Pract Endocrinol Metab 2007;3:713-20.
3. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: part I. basic mechanisms and in vivo monitoring of ROS. Circulation 2003;108:1912-6. (Pubitemid 37296532)
4. Sorescu D, Weiss D, Lassegue B, et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002;105:1429-35. (Pubitemid 34263273)
5. Brasen JH, Leppanen O, Inkala M, et al. Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta. J Am Coll Cardiol 2007;50:2249-53. (Pubitemid 350166823)
6. Powis G, Briehl M, Oblong J. Redox signaling and the control of cell growth and death. Pharmacol Ther 1995;68:149-73.
7. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 1998;273:6297-302. (Pubitemid 28144719)
8. Nonn L, Williams RR, Erickson RP, Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 2003;23:916-22. (Pubitemid 36133510)
9. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
10. Masuda H, Kalka C, Asahara T. Endothelial progenitor cells for regeneration. Hum Cell 2000;13:153-60.
11. Shioji K, Nakamura H, Masutani H, Yodoi J. Redox regulation by thioredoxin in cardiovascular diseases. Antioxid Redox Signal 2003;5:795-802. (Pubitemid 37462063)
12. Haendeler J, Tischler V, Hoffmann J, Zeiher AM, Dimmeler S. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett 2004;577:427-33. (Pubitemid 39535325)
13. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000;97:3422-7. (Pubitemid 30183318)
14. O'Donnell J, Mille-Baker B, Laffan M. Human umbilical-vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens. J Vasc Res 2000;37:540-7.
15. Gershoni JM, Palade GE. Electrophoretic transfer of proteins from sodium docedcyl sulfate-polyacrylamide gels to a positively charged membrane filter. Anal Biochem 1982;124:396-405.
16. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36. (Pubitemid 20209469)
17. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events inpatients with coronary artery disease. Circulation 2001;104:2673-8. (Pubitemid 33108132)
18. Fridlyand LE, Philipson LH. Oxidative reactive species in cell injury: mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci 2005;1066:136-51.
19. Cho YS, Choi JH, Zhang SY, et al. Relationship of polymorphisms in the oxidative stress related genes-paraoxonase and p22phox to variant angina and coronary artery stenosis in Korean. Korean Circ J 2003;33:104-12.
20. Kim KS, Han HS, Lee YS, et al. Plasma thioredoxin level and its correlation to myocardial damage in patients with acute myocardial infarction who underwent successful primary angioplasty. Korean Circ J 2006;36:39-45.
21. Ide T, Tsutsui H, Kniganwa S, et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999;85:357-63. (Pubitemid 29398868)
22. Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 2001;41:261-95. (Pubitemid 32385890)
23. Becker K, Gromer S, Schirmer RH, Muller S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 2000;267:6118-25.
24. Okuda M, Inoue N, Azumi H, et al. Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1483-7. (Pubitemid 34219812)
25. Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation 2004;110:856-61. (Pubitemid 39096015)
26. Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin-binding protein-2/vitamin D(3) upregulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999;274:21645-50.
27. Yoshioka J, Schulze PC, Cupesi M, et al. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 2004;109:2581-6. (Pubitemid 38720560)
28. World CJ, Yamawaki H, Berk BC. Thioredoxin in the cardiovascular system. J Mol Med 2006;84:997-1003.
29. Bleeke T, Zhang H, Madamanchi N, Patterson C, Faber JE. Catecholoamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 2004;94:37-45. (Pubitemid 38064096)
30. Divakaran V, Mann DL. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 2008;103:1072-83.